Large-scale metabolomic profiling and incident non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Large-scale metabolomic profiling and incident non-alcoholic fatty liver disease

Published:2023-07 Issue:7 Volume:26 Page:107127
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Gagnon Eloi^ORCID,Manikpurage Hasanga D.,Mitchell Patricia L.,Girard Arnaud,Gobeil Émilie,Bourgault Jérôme,Bégin Frédéric,Marette André,Thériault Sébastien,Arsenault Benoit J.

Funder

Canadian Institutes of Health Research

Fonds de Recherche du Québec - Santé

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference49 articles.

1. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease;Kanwal;Gastroenterology,2018

2. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future;Araújo;Liver Int.,2018

3. Advancing the global public health agenda for NAFLD: a consensus statement;Lazarus;Nat. Rev. Gastroenterol. Hepatol.,2022

4. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes;Godoy-Matos;Diabetol. Metab. Syndr.,2020

5. Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests;Masoodi;Nat. Rev. Gastroenterol. Hepatol.,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics and Lipidomics for Studying Metabolic Syndrome: Insights into Cardiovascular Diseases, Type 1 & 2 Diabetes, and Metabolic Dysfunction-Associated Steatotic Liver Disease;Physiological Research;2024-08-31

2. Dietary pattern modifies the risk of MASLD through metabolomic signature;JHEP Reports;2024-08

3. Metabolic dysfunction-associated steatotic liver disease: Recent turning points for its diagnosis and management;Metabolism;2024-08

4. Hypertriglyceridemia and Multiorgan Disease Among U.S. Adults;JACC: Advances;2024-05

5. Gender-specific effect of dietary fatty acids on nonalcoholic fatty liver disease;2024-02-15